Published October 2018 | Version v1
Journal article

The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis

  • 1. Division of Cardiology, Denver VA Medical Center and University of Colorado, Denver (United States)
  • 2. Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY (United States)
  • 3. 1st Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki (Greece)
  • 4. Division of Cardiology, Medstar, Washington Hospital Center, DC (United States)
  • 5. Cardiology Working Group, Society of Junior Doctors, Athens (Greece)

Description

Transcatheter aortic valve implantation (TAVI) is a safe and effective alternative to surgical aortic valve replacement (SAVR) for the treatment of severe aortic valve stenosis (AS). The impact of concomitant baseline elevated pulmonary artery pressures on outcomes after TAVI has not been established, since different studies used different definitions of pulmonary hypertension (PH).

Additional details

Identifiers

DOI
10.1016/j.carrev.2018.03.015;
PII
S1553838918301180;

Publishing Information

Journal Title
Cardiovascular Revascularization Medicine (Print)
Journal Volume
19
Journal Issue
7
Journal Page Range
p. 859-867
ISSN
1553-8389

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
55055137
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ARTERIES; HYPERTENSION; MORTALITY; PATIENTS; PH VALUE; REVIEWS; SURGERY
Descriptors DEC
BLOOD VESSELS; BODY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DISEASES; DOCUMENT TYPES; MEDICINE; ORGANS; SYMPTOMS; VASCULAR DISEASES

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.